BANCR positively regulates the HIF‑1α/VEGF‑C/VEGFR‑3 pathway in a hypoxic microenvironment to promote lymphangiogenesis in pancreatic cancer cells

Hao,Shaolong; Han,Wei; Ji,Yu; Sun,Hao; Shi,Haowei; Ma,Jihong; Yip,James; Ding,Yuchuan

doi:10.3892/ol.2022.13542

BANCR positively regulates the HIF‑1α/VEGF‑C/VEGFR‑3 pathway in a hypoxic microenvironment to promote lymphangiogenesis in pancreatic cancer cells

Authors:
- Shaolong Hao
- Wei Han
- Yu Ji
- Hao Sun
- Haowei Shi
- Jihong Ma
- James Yip
- Yuchuan Ding
View Affiliations

Affiliations: Department of General Surgery, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, P.R. China, Central Laboratory Department, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, P.R. China, Health Care Ward, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, P.R. China, Department of Research and Development Center, John D. Dingell VA Medical Center, Detroit, MI 48201, USA
Published online on: October 11, 2022 https://doi.org/10.3892/ol.2022.13542
Article Number: 422
Copyright: © Hao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to explore the effects of BRAF‑activated non‑protein coding RNA (BANCR) on pancreatic microlymphangiogenesis in pancreatic cancer (PC) and its molecular mechanism under hypoxic conditions. Reverse transcription‑quantitative PCR (RT‑qPCR) was used to detect the expression of BANCR in SW1990 and PANC‑1 PC cell lines under normoxic and hypoxic conditions. Subsequently, the expression of BANCR in the PC cells was knocked down using small interfering RNAs (siRNAs). Western blotting and RT‑qPCR analyses were performed to detect the expression of hypoxia‑inducible factor (HIF‑1α), VEGF‑C and VEGFR‑3 in the transfected cells. In addition, the transfected PC cells were co‑cultured with human lymphatic endothelial cells and the lymphatic microvessel density (MLVD) was detected under normal and hypoxic conditions. Furthermore, HIF‑1α expression in the PC cells was knocked down using siRNAs, and VEGF‑C and VEGFR‑3 mRNA expression in the HIF‑1α knockdown cells was detected using RT‑qPCR. The results showed that the expression of BANCR in the SW1990 and PANC‑1 PC cell lines was significantly higher than that in human pancreatic duct endothelial cells. Additionally, the expression of BANCR was significantly increased in PC cells under hypoxic conditions compared with normoxic conditions. The MLVD of PC cells under hypoxic conditions was significantly higher compared with that under normoxic conditions, and the MLVD in the si‑BANCR group was lower than that in the si‑NC group, indicating that si‑BANCR downregulated MLVD. These results indicate that BANCR positively regulated the expression of HIF‑1α in PC cells at the transcriptional and translational levels. Finally, the expression levels of VEGF‑C and VEGFR‑3 in PC cells were significantly reduced when BANCR or HIF‑1α expression was knocked down. In conclusion, the results demonstrate that the expression of BANCR in PC cells was significantly increased under hypoxic conditions and suggest that BANCR promoted tumor cell lymphangiogenesis by upregulating the HIF‑1α/VEGF‑C/VEGFR‑3 pathway, which plays an important role in the process of PC lymph node metastasis.

View Figures

View References

1	Mizrahi JD, Surana R, Valle JW and Shroff RT: Pancreatic cancer. Lancet. 395:2008–2020. 2020. View Article : Google Scholar : PubMed/NCBI
2	Schwarz RE and Smith DD: Extent of lymph node retrieval and pancreatic cancer survival: Information from a large US population database. Ann Surg Oncol. 13:1189–1200. 2006. View Article : Google Scholar : PubMed/NCBI
3	Chari ST, Sharma A and Maitra A: Early detection of sporadic pancreatic ductal adenocarcinoma: Problems, promise, and prospects. Ann Intern Med. 172:558–559. 2020. View Article : Google Scholar : PubMed/NCBI
4	Wu X, Xia T, Cao M, Zhang P, Shi G, Chen L, Zhang J, Yin J, Wu P, Cai B, et al: LncRNA BANCR promotes pancreatic cancer tumorigenesis via modulating MiR-195-5p/Wnt/β-catenin signaling pathway. Technol Cancer Res Treat. 18:15330338198879622019. View Article : Google Scholar : PubMed/NCBI
5	Ran S, Volk L, Hall K and Flister MJ: Lymphangiogenesis and lymphatic metastasis in breast cancer. Pathophysiology. 17:229–251. 2010. View Article : Google Scholar : PubMed/NCBI
6	Sundar SS and Ganesan TS: Role of lymphangiogenesis in cancer. J Clin Oncol. 25:4298–4307. 2007. View Article : Google Scholar : PubMed/NCBI
7	Stacker SA, Williams SP, Karnezis T, Shayan R, Fox SB and Achen MG: Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer. 14:159–172. 2014. View Article : Google Scholar : PubMed/NCBI
8	Choi JU, Chung SW, Al-Hilal TA, Alam F, Park J, Mahmud F, Jeong JH, Kim SY and Byun Y: A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway. Biomaterials. 139:56–66. 2017. View Article : Google Scholar : PubMed/NCBI
9	Ochi N, Matsuo Y, Sawai H, Yasuda A, Takahashi H, Sato M, Funahashi H, Okada Y and Manabe T: Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis. Pancreas. 34:444–451. 2007. View Article : Google Scholar : PubMed/NCBI
10	Kung JT, Colognori D and Lee JT: Long noncoding RNAs: Past, present, and future. Genetics. 193:651–669. 2013. View Article : Google Scholar : PubMed/NCBI
11	Jiang J, Shi SH, Li XJ, Sun L, Ge QD, Li C and Zhang W: Long non-coding RNA BRAF-regulated lncRNA 1 promotes lymph node invasion, metastasis and proliferation, and predicts poor prognosis in breast cancer. Oncol Lett. 15:9543–9552. 2018.PubMed/NCBI
12	Shen X, Bai Y, Luo B and Zhou X: Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer. Biol Res. 50:322017. View Article : Google Scholar : PubMed/NCBI
13	Flockhart RJ, Webster DE, Qu K, Mascarenhas N, Kovalski J, Kretz M and Khavari PA: BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration. Genome Res. 22:1006–1014. 2012. View Article : Google Scholar : PubMed/NCBI
14	Fang S, Liu Z, Guo Q, Chen C, Ke X and Xu G: High BANCR expression is associated with worse prognosis in human malignant carcinomas: An updated systematic review and meta-analysis. BMC Cancer. 20:8702020. View Article : Google Scholar : PubMed/NCBI
15	Fan YH, Ye MH, Wu L, Wu MJ, Lu SG and Zhu XG: BRAF-activated lncRNA predicts gastrointestinal cancer patient prognosis: A meta-analysis. Oncotarget. 8:6295–6303. 2017. View Article : Google Scholar : PubMed/NCBI
16	Zhou T and Gao Y: Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma. World J Surg Oncol. 14:82016. View Article : Google Scholar : PubMed/NCBI
17	Liu ZH, Yang TX, Xu ZP, Lv J, Cao XF, et al: Long non-coding RNA BANCR expression in esophageal squamous cell carcinoma and its effects on cell growth and invasion. Prog Mod Biomed. 16:4622–4627. 2016.(In Chinese).
18	Lou KX, Li ZH, Wang P, Liu Z, Chen Y, Wang XL and Cui HX: Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion. Eur Rev Med Pharmacol Sci. 22:1358–1365. 2018.PubMed/NCBI
19	Zheng H, Xu J, Hao S, Liu X, Ning J, Song X, Jiang L and Liu Z: Expression of BANCR promotes papillary thyroid cancer by targeting thyroid stimulating hormone receptor. Oncol Lett. 16:2009–2015. 2018.PubMed/NCBI
20	Stojanović S, Šelemetjev S, Đorić I, Rončević J, Janković Miljuš J, Živaljević V and Išić Denčić T: Elevated BANCR expression levels have different effects on papillary thyroid carcinoma progression depending on the presence of the BRAFV600E mutation. Eur J Surg Oncol. 46:1835–1842. 2020. View Article : Google Scholar : PubMed/NCBI
21	Koong AC, Mehta VK, Le QT, Fisher GA, Terris DJ, Brown JM, Bastidas AJ and Vierra M: Pancreatic tumors show high levels of hypoxia. Int J Radiat Oncol Biol Phys. 48:919–922. 2000. View Article : Google Scholar : PubMed/NCBI
22	Dauer P, Nomura A, Saluja A and Banerjee S: Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters. Pancreatology. 17:7–12. 2017. View Article : Google Scholar : PubMed/NCBI
23	Kang G, Hu M, Ren H, Wang J, Cheng X, Li R, Yuan B, Balan Y, Bai Z and Huang H: VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer in vivo. Cancer Biol Med. 18:772–787. 2021. View Article : Google Scholar : PubMed/NCBI
24	Yang QK, Wang XX, Wang Y and Ni N: Integrative analysis reveals the landscape of hypoxia-inducible factor (HIF) family genes in pan-cancer. J Oncol. 2020:88731042020. View Article : Google Scholar : PubMed/NCBI
25	Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
26	Harris AL: Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer. 2:38–47. 2002. View Article : Google Scholar : PubMed/NCBI
27	Ye LY, Zhang Q, Bai XL, Pankaj P, Hu QD and Liang TB: Hypoxia-inducible factor 1α expression and its clinical significance in pancreatic cancer: A meta-analysis. Pancreatology. 14:391–397. 2014. View Article : Google Scholar : PubMed/NCBI
28	Jin X, Dai L, Ma Y, Wang J and Liu Z: Implications of HIF-1α in the tumorigenesis and progression of pancreatic cancer. Cancer Cell Int. 20:2732020. View Article : Google Scholar : PubMed/NCBI
29	Liu M, Zhong J, Zeng Z, Huang K, Ye Z, Deng S, Chen H, Xu F, Li Q and Zhao G: Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein. Theranostics. 9:4795–4810. 2019. View Article : Google Scholar : PubMed/NCBI
30	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
31	Liu HD, Zhao LH, Zhang YF, Li YL, Li XD, Yang SC, Li YM and Nie CS: Morphologic features of lymphatic in periphery region of gastric carcinoma and colon carcinoma. Ai Zheng. 24:699–703. 2005.PubMed/NCBI
32	Sipos B, Kojima M, Tiemann K, Klapper W, Kruse ML, Kalthoff H, Schniewind B, Tepel J, Weich H, Kerjaschki D and Klöppel G: Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis. J Pathol. 207:301–312. 2005. View Article : Google Scholar : PubMed/NCBI
33	Keklikoglou I, Hosaka K, Bender C, Bott A, Koerner C, Mitra D, Will R, Woerner A, Muenstermann E, Wilhelm H, et al: MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes. Oncogene. 34:4867–4878. 2015. View Article : Google Scholar : PubMed/NCBI
34	Yang H, Kim C, Kim MJ, Schwendener RA, Alitalo K, Heston W, Kim I, Kim WJ and Koh GY: Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer. Mol Cancer. 10:362011. View Article : Google Scholar : PubMed/NCBI
35	Winder T and Lenz HJ: Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancer. Gastroenterology. 138:2163–2176. 2010. View Article : Google Scholar : PubMed/NCBI
36	Zhang G and Cai J: Evaluation of prognostic value of lncRNA BANCR in tumor patients: A systematic review and meta-analysis. J BUON. 24:2553–2559. 2019.PubMed/NCBI
37	Cheng P, Jin G, Hu X, Shi M, Zhang Y, Liu R, Zhou Y, Shao C, Zheng J and Zhu M: Analysis of tumor-induced lymphangiogenesis and lymphatic vessel invasion of pancreatic carcinoma in the peripheral nerve plexus. Cancer Sci. 103:1756–1763. 2012. View Article : Google Scholar : PubMed/NCBI
38	Nakajima T, Anayama T, Koike T, Shingyoji M, Castle L, Kimura H, Yoshino I and Yasufuku K: Endobronchial ultrasound doppler image features correlate with mRNA expression of HIF1-α and VEGF-C in patients with non-small-cell lung cancer. J Thorac Oncol. 7:1661–1667. 2012. View Article : Google Scholar : PubMed/NCBI
39	Schoppmann SF, Fenzl A, Schindl M, Bachleitner-Hofmann T, Nagy K, Gnant M, Horvat R, Jakesz R and Birner P: Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer. Breast Cancer Res Treat. 99:135–141. 2006. View Article : Google Scholar : PubMed/NCBI
40	Katsuta M, Miyashita M, Makino H, Nomura T, Shinji S, Yamashita K, Tajiri T, Kudo M, Ishiwata T and Naito Z: Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer. Exp Mol Pathol. 78:123–130. 2005. View Article : Google Scholar : PubMed/NCBI
41	Jun JC, Rathore A, Younas H, Gilkes D and Polotsky VY: Hypoxia-inducible factors and cancer. Curr Sleep Med Rep. 3:1–10. 2017. View Article : Google Scholar : PubMed/NCBI